Since Alzheimer’s is generally associated with older adults, it can be difficult for a younger person to get an accurate diagnosis. People who might be eligible for anti-amyloid medications may face barriers from their private insurers, which may not provide coverage for the drug. Financial concerns are also more acute, including navigating disability benefits, transitioning from dual to single income, and planning long-term care far earlier than expected.